RecruitingNot ApplicableNCT07159789

Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis

Non-Invasive Neuromodulation in MS Induced Spastic Paraparesis


Sponsor

Clinique Neuro-Outaouais

Enrollment

60 participants

Start Date

Oct 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Study the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This trial tests whether repetitive transcranial magnetic stimulation (rTMS) — a non-invasive brain stimulation technique using magnetic pulses — can reduce leg stiffness and spasticity in people with multiple sclerosis (MS). Spasticity in MS causes painful muscle tightness, mainly in the legs. **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with MS (by 2017 McDonald Criteria) - You have moderate to moderately severe disability with significant leg spasticity (EDSS 3.0–6.5, pyramidal score ≥3) - Your MS symptoms have been stable for at least 30 days with no recent relapses **You may NOT be eligible if...** - You have another neurological disorder adding to your disability - You have a significant heart condition, psychiatric illness, or severe lung disease - You recently changed your MS disease-modifying therapy (within 3 months) - You plan to start new spasticity medications during the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERepetitive Transcranial Magnetic Stimulation

Treatment with the rTMS or sham rTMS will be scheduled daily 5x per week for a total of 6 consecutive weeks followed, after a 6 week pause, by another treatment session of 6 weeks where all patients will receive active rTMS treatment


Locations(1)

Clinique Neuro-Outaouais

Gatineau, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07159789


Related Trials